Skip to main content
Clinical Trials/IRCT2014110519813N1
IRCT2014110519813N1
Completed
未知

Selenium supplementation effects on serum asymmetric dimethylarginine (ADMA) ,free androgen index (FAI) and visceral adiposity index (VAI) in women with polycystic ovary syndrome ; randomized clinical trial

Tehran University Of Medical Sciences0 sites64 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
polycystic ovarian syndrome.
Sponsor
Tehran University Of Medical Sciences
Enrollment
64
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
Female

Investigators

Eligibility Criteria

Inclusion Criteria

  • The inclusion criteria are as follows: women between 18 and 45
  • years old; diagnosed PCOS based on the Rotterdam criteria; non smokers
  • the exclution criteria are : having an androgen\-secreting tumor, Cushing syndrome, congenital adrenal hyperplasia, hyperprolactinemia, and/or virilism; impaired fasting glucose; diabetes, hypothyroidism; hyperthyroidism; liver disease; renal dysfunction; cardiovascular disease or dysfunction; pregnancy or breas feeding; taking medications known to affect metabolic parameters , such as corticosteroid drugs , ocp, selenium or multivitamin and mineral supplements

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials